Using clinical samples, we observed a significant positive correlation between the gene expression of FoxM1 and that of HMGCR, a rate limiting enzyme for mevalonate pathway, or SREBP2, a master regulator of the mevalonate pathway [14], in HCC tissues. The gene discussed is SREBF2; the disease is hepatocellular carcinoma.